2017
DOI: 10.1590/1677-5449.007316
|View full text |Cite
|
Sign up to set email alerts
|

Terapia fibrinolítica sistêmica no tromboembolismo pulmonar

Abstract: Pulmonary thromboembolism remains a major therapeutic challenge for specialists and, despite investment and the consequent developments in diagnosis, prophylaxis, and treatment, the condition is still the leading cause of avoidable deaths in hospital settings. There is still great uncertainty with relation to the profile of patients who will actually benefit from systemic fibrinolytic treatment, without being exposed to serious risk of bleeding. There are tools that can help to identify patients who will benef… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 61 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?